Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring

被引:0
|
作者
Wolpert, Howard [1 ]
Rodbard, David [2 ]
Xue, Jie [3 ]
Johnson, Jennal [3 ]
Dassau, Eyal [3 ]
机构
[1] Boston Med Ctr, Boston, MA USA
[2] Biomed Informat Consultants LLC, Potomac, MD USA
[3] Eli Lilly & Co, Indianapolis, IN USA
关键词
continuous glucose monitoring (CGM); glycaemic control; hypoglycaemia; insulin therapy; observational study; INTERNATIONAL CONSENSUS;
D O I
10.1111/dom.16249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Connected insulin pens (CIPs) provide insulin dosing data that can be leveraged to drive improvements in glycaemic control. To realize this potential in routine care, insulin data need to be distilled into actionable insights for clinicians. We describe two algorithms for detecting glucose excursions using continuous glucose monitoring (CGM) data and then link excursions to CIP data to derive "insulin metrics" characterizing suboptimal bolus dosing practices. Materials and Methods: This post hoc analysis used CGM and CIP data from a 12-week observational study (: NCT03368807) of 64 adults with type 1 or type 2 diabetes receiving multiple daily injection insulin therapy and glycated haemoglobin >= 8%. Two updated algorithms were applied to analyse glucose excursions associated with pre-meal boluses, missed bolus doses (MBDs), delayed boluses and correction boluses. Results: Glycaemic metrics obtained using both algorithms were similar. Time in range (%TIR) was lower, and time above range (%TAR) and glycaemic variability (%GV) were higher, on days with MBDs. Compared with pre-meal boluses, delayed and correction boluses were followed by glucose excursions with larger change in glucose, longer duration with glucose >180 mg/dL, lower post-excursion %TIR and higher post-excursion %TAR; excursions following MBDs showed lower %TIR, higher %TAR and lower percent recovery. Glucose excursions were larger and longer when CGM was masked than when unmasked. Conclusions: This analysis demonstrates "insulin metrics"-characterizations of insulin dosing behaviour derived from integrated CGM and CIP data-and provides a foundation for future work that will expand the understanding of an individual's insulin self-administration practices and improve clinical decision-making.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Continuous glucose monitoring system glycaemic variability in pediatric type 1 diabetes patients on basal insulin plus prandial insulin: utility of Fourier analysis
    Miller, M.
    White, N. H.
    Chase, H.
    DIABETOLOGIA, 2007, 50 : S420 - S420
  • [32] Superior Glycaemic Control Effects with Insulin Degludec (IDeg) to Insulin Glargine (IGlar) in Diabetic Hemodialysis (HD) Patients Assessed by Continuous Glucose Monitoring (CGM)
    Funakoshi, Satoshi
    Hashiguchi, Jyunichiro
    Komine, Maya
    Sato, Yasutaka
    Etoh, Rica
    Harada, Takashi
    DIABETES, 2014, 63 : A17 - A17
  • [33] Comparison of glycaemic variations in Japanese patients with type 1 diabetes receiving insulin detemir vs insulin degludec as assessed by Continuous Glucose Monitoring (CGM)
    Takahashi, H.
    Nishimura, R.
    Onda, Y.
    Tsujino, D.
    Ando, K.
    Utsunomiya, K.
    DIABETOLOGIA, 2015, 58 : S473 - S474
  • [34] Evaluation of a novel continuous glucose monitoring guided system for adjustment of insulin dosing - PumpTune: a randomized controlled trial
    Anderson, Donald
    Phelan, Helen
    Jones, Katie
    Smart, Carmel
    Oldmeadow, Christopher
    King, Bruce
    Crock, Patricia
    PEDIATRIC DIABETES, 2016, 17 (07) : 478 - 482
  • [35] Association of self monitoring of blood glucose, medication adherence, and glycaemic control in diabetes patients not using insulin
    Virdi, N. S.
    Raja, P.
    Daskiran, M.
    Kozma, C.
    Nigam, S.
    DIABETOLOGIA, 2011, 54 : S393 - S394
  • [36] Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes
    Moya Chimenti, Elisa
    Herranz de la Morena, Lucrecia
    Martin Vaquero, Pilar
    Saez-de-ibarra, Lourdes
    Garcia Dominguez, Maria
    Pallardo Sanchez, Luis Felipe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) : E57 - E59
  • [37] Glycaemic control with once weekly basal insulin Fc in persons with type 2 diabetes using continuous glucose monitoring in a phase 2 study
    Kazda, C.
    Chien, J.
    Zhang, Q.
    Chigutsa, E.
    Landschulz, W.
    Wullenweber, P.
    Haupt, A.
    Frias, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 113 - 113
  • [38] Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes
    Lee, Da Young
    Kim, Namho
    Jung, Inha
    Park, So Young
    Yu, Ji Hee
    Seo, Ji A.
    Park, Sung-Min
    Kim, Nan Hee
    DIABETES, 2023, 72
  • [39] COMPARISON OF INSULIN GLULISINE VERSUS HUMAN REGULAR INSULIN IN PATIENTS RECEIVING PREDNISOLONE WITH DIABETES USING CONTINUOUS GLUCOSE MONITORING
    Uzawa, H.
    Ogawa, T.
    Tanimoto, M.
    Yasui, M.
    Takemura, T.
    Takahashi, R.
    Masuzawa, M.
    Ogawa, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A141 - A141
  • [40] Evaluation of the quality of basal insulin replacement with insulin glargine in type 1 diabetes using continuous glucose monitoring system
    Howorka, K
    Pumprla, J
    Gabriel, M
    Grillmayr, H
    Schabmann, A
    DIABETES, 2002, 51 : A123 - A123